~~<i id='80FDA4BF28'><strike id='80FDA4BF28'><tt id='80FDA4BF28'><pre id='80FDA4BF28'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

hotspot

author：focus 2025-09-30 05:04:06 - browse：58117

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： AI models in health care face new federal disclosure requirements

knowledge

explore

entertainment

hotspot

explore

AdobeOliverMcGowanwas18yearsoldwhenhewashospitalizedinEnglandwithrecurrentseizuresandpneumonia.Hewas

WSS

Astronauts get first look at the spacecraft that will fly them around the moon

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

AI models in health care face new federal disclosure requirements

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Biden praises World Series champion Astros for impact off the field during White House celebration

Radiology is caught between AI's potential and concern for patients

entertainment

hotspot

knowledge

Drug repurposing or repositioning? The language matters

Roche to buy Carmot Therapeutics, developer of obesity drugs

Jerome Adams on the need for new antivirals for Covid

STAT letters to the editor on burnt

Medicare proposal to cover medical devices draws a mixed reaction

Hospitals use virtual reality to design more inclusive rooms for kids

Apple is now the first public company to be valued at $3 trillion

Roche to buy Carmot Therapeutics, developer of obesity drugs

Malaria cases in Florida and Texas: Here’s what you need to know

STAT letters to the editor on burnt

explore

‘The Bear’ and hospitality in hospitals

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

FDA needs staff influx to meet gene therapy needs, Marks says

An Ebola outbreak presents a new mystery involving children

CMS should re

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

entertainment

hotspot

hotspot

explore